176 related articles for article (PubMed ID: 16260277)
21. Utilization of antihepatocyte clone OCH1E5 (Hep Par 1) in histological evaluation of liver tumors.
Amarapurkar AD; Rege JD; Joshi AS; Vaiphei K; Amarapurkar DN
Indian J Pathol Microbiol; 2006 Jul; 49(3):341-4. PubMed ID: 17001880
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic utility of GLUT1 in the differential diagnosis of liver carcinomas.
Roh MS; Jeong JS; Kim YH; Kim MC; Hong SH
Hepatogastroenterology; 2004; 51(59):1315-8. PubMed ID: 15362741
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the expression of agrin, a basement membrane heparan sulfate proteoglycan, in cholangiocarcinoma and hepatocellular carcinoma.
Batmunkh E; Tátrai P; Szabó E; Lódi C; Holczbauer A; Páska C; Kupcsulik P; Kiss A; Schaff Z; Kovalszky I
Hum Pathol; 2007 Oct; 38(10):1508-15. PubMed ID: 17640714
[TBL] [Abstract][Full Text] [Related]
24. Immunoperoxidase staining as a diagnostic aid for hepatocellular carcinoma.
Christensen WN; Boitnott JK; Kuhajda FP
Mod Pathol; 1989 Jan; 2(1):8-12. PubMed ID: 2466290
[TBL] [Abstract][Full Text] [Related]
25. Histologic differentiation of hepatocellular carcinoma from adenocarcinoma by a simple panel: evaluation of the pitfalls.
Geramizadeh B; Boub R; Rahsaz M
Indian J Pathol Microbiol; 2007 Jul; 50(3):507-10. PubMed ID: 17883119
[TBL] [Abstract][Full Text] [Related]
26. Is histological diagnosis of primary liver carcinomas with fibrous stroma reproducible among experts?
Malouf G; Falissard B; Azoulay D; Callea F; Ferrell LD; Goodman ZD; Hayashi Y; Hsu HC; Hubscher SG; Kojiro M; Ng IO; Paterson AC; Reynes M; Zafrani ES; Emile JF
J Clin Pathol; 2009 Jun; 62(6):519-24. PubMed ID: 19155239
[TBL] [Abstract][Full Text] [Related]
27. Comparative analysis of alternative and traditional immunohistochemical markers for the distinction of ovarian sertoli cell tumor from endometrioid tumors and carcinoid tumor: A study of 160 cases.
Zhao C; Bratthauer GL; Barner R; Vang R
Am J Surg Pathol; 2007 Feb; 31(2):255-66. PubMed ID: 17255771
[TBL] [Abstract][Full Text] [Related]
28. [Albumin mRNA and pCEA in the histopathologic diagnosis of hepatocellular carcinoma].
Foschini MP; Macchia S; Baccarini P; Milandri GL; Losi L; Spongano P; Panarelli M; Dal Monte PR; Eusebi V
Pathologica; 1999 Aug; 91(4):260-7. PubMed ID: 10630075
[TBL] [Abstract][Full Text] [Related]
29. Role of CD10 immunochemistry in differentiating hepatocellular carcinoma from metastatic carcinoma of the liver.
Ahuja A; Gupta N; Kalra N; Srinivasan R; Chawla Y; Rajwanshi A
Cytopathology; 2008 Aug; 19(4):229-35. PubMed ID: 18070122
[TBL] [Abstract][Full Text] [Related]
30. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].
Tátrai P
Magy Onkol; 2008 Dec; 52(4):379-83. PubMed ID: 19068466
[TBL] [Abstract][Full Text] [Related]
31. High mobility group A1 is expressed in metastatic adenocarcinoma to the liver and intrahepatic cholangiocarcinoma, but not in hepatocellular carcinoma: its potential use in the diagnosis of liver neoplasms.
Abe N; Watanabe T; Izumisato Y; Suzuki Y; Masaki T; Mori T; Sugiyama M; Fusco A; Atomi Y
J Gastroenterol; 2003; 38(12):1144-9. PubMed ID: 14714251
[TBL] [Abstract][Full Text] [Related]
32. Classification of hepatocellular carcinoma according to hepatocellular and biliary differentiation markers. Clinical and biological implications.
Wu PC; Fang JW; Lau VK; Lai CL; Lo CK; Lau JY
Am J Pathol; 1996 Oct; 149(4):1167-75. PubMed ID: 8863666
[TBL] [Abstract][Full Text] [Related]
33. Discriminating hepatocellular carcinoma from metastatic carcinoma on fine-needle aspiration biopsy of the liver: the utility of immunocytochemical panel.
Saleh HA; Aulicino M; Zaidi SY; Khan AZ; Masood S
Diagn Cytopathol; 2009 Mar; 37(3):184-90. PubMed ID: 19170172
[TBL] [Abstract][Full Text] [Related]
34. Down-regulation of aquaporin-1 in intrahepatic cholangiocarcinoma is related to tumor progression and mucin expression.
Aishima S; Kuroda Y; Nishihara Y; Taguchi K; Iguchi T; Taketomi A; Maehara Y; Tsuneyoshi M
Hum Pathol; 2007 Dec; 38(12):1819-25. PubMed ID: 17854859
[TBL] [Abstract][Full Text] [Related]
35. Immunocytochemical staining of fine-needle aspiration biopsies of the liver as a diagnostic tool for hepatocellular carcinoma.
Johnson DE; Powers CN; Rupp G; Frable WJ
Mod Pathol; 1992 Mar; 5(2):117-23. PubMed ID: 1374187
[TBL] [Abstract][Full Text] [Related]
36. The utility of hepatocyte paraffin 1 antibody in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma and metastatic carcinoma.
Shiran MS; Isa MR; Sherina MS; Rampal L; Hairuszah I; Sabariah AR
Malays J Pathol; 2006 Dec; 28(2):87-92. PubMed ID: 18376797
[TBL] [Abstract][Full Text] [Related]
37. An immunohistochemical study of hepatic atypical adenomatous hyperplasia, hepatocellular carcinoma, and cholangiocarcinoma with alpha-fetoprotein, carcinoembryonic antigen, CA19-9, epithelial membrane antigen, and cytokeratins 18 and 19.
Tsuji M; Kashihara T; Terada N; Mori H
Pathol Int; 1999 Apr; 49(4):310-7. PubMed ID: 10365850
[TBL] [Abstract][Full Text] [Related]
38. 'Scirrhous' type hepatocellular carcinomas: a special reference to expression of cytokeratin 7 and hepatocyte paraffin 1.
Matsuura S; Aishima S; Taguchi K; Asayama Y; Terashi T; Honda H; Tsuneyoshi M
Histopathology; 2005 Oct; 47(4):382-90. PubMed ID: 16178893
[TBL] [Abstract][Full Text] [Related]
39. Distinction between hepatocellular carcinoma, cholangiocarcinoma, and metastatic carcinoma based on immunohistochemical staining for carcinoembryonic antigen and for cytokeratin 19 on paraffin sections.
Balaton AJ; Nehama-Sibony M; Gotheil C; Callard P; Baviera EE
J Pathol; 1988 Dec; 156(4):305-10. PubMed ID: 2465399
[TBL] [Abstract][Full Text] [Related]
40. Integrins as differential cell lineage markers of primary liver tumors.
Volpes R; van den Oord JJ; Desmet VJ
Am J Pathol; 1993 May; 142(5):1483-92. PubMed ID: 7684197
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]